Hillhouse-backed biotech firm Jacobio plans up to $400m Hong Kong IPO

Hillhouse-backed biotech firm Jacobio plans up to $400m Hong Kong IPO

Photo: Pexels

Jacobio Pharmaceuticals Co., a Chinese biotechnology company focusing on cancer treatments, is planning a Hong Kong initial public offering as soon as this year, according to people familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter